Accretive Wealth Partners LLC Cuts Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Accretive Wealth Partners LLC lessened its position in Teleflex Incorporated (NYSE:TFXFree Report) by 2.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,278 shares of the medical technology company’s stock after selling 82 shares during the quarter. Accretive Wealth Partners LLC’s holdings in Teleflex were worth $817,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Lindbrook Capital LLC lifted its position in Teleflex by 75.3% during the fourth quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock worth $34,000 after buying an additional 58 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its holdings in shares of Teleflex by 418.5% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock worth $35,000 after acquiring an additional 113 shares during the period. Covestor Ltd boosted its position in shares of Teleflex by 305.6% during the 3rd quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock valued at $29,000 after acquiring an additional 110 shares during the last quarter. Janiczek Wealth Management LLC grew its holdings in shares of Teleflex by 227.1% in the fourth quarter. Janiczek Wealth Management LLC now owns 157 shares of the medical technology company’s stock valued at $39,000 after purchasing an additional 109 shares during the period. Finally, Venturi Wealth Management LLC increased its position in Teleflex by 33.3% during the fourth quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock worth $46,000 after purchasing an additional 46 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on TFX shares. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Truist Financial reduced their target price on Teleflex from $240.00 to $219.00 and set a “hold” rating on the stock in a research report on Friday, May 3rd. JMP Securities reiterated a “market outperform” rating and set a $285.00 price target on shares of Teleflex in a report on Friday, February 23rd. Royal Bank of Canada reduced their price objective on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Friday, May 3rd. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and an average price target of $257.29.

Check Out Our Latest Stock Analysis on Teleflex

Insider Buying and Selling

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the sale, the vice president now owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.43% of the stock is currently owned by insiders.

Teleflex Stock Performance

Shares of Teleflex stock opened at $209.07 on Friday. The stock has a market capitalization of $9.85 billion, a price-to-earnings ratio of 33.56, a price-to-earnings-growth ratio of 2.00 and a beta of 1.13. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.51 and a quick ratio of 1.41. The business has a 50-day moving average of $211.47 and a 200 day moving average of $228.28. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $262.97.

Teleflex (NYSE:TFXGet Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $3.21 EPS for the quarter, beating the consensus estimate of $3.07 by $0.14. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The business had revenue of $737.80 million during the quarter, compared to analyst estimates of $726.85 million. During the same quarter last year, the firm posted $3.09 earnings per share. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year. As a group, sell-side analysts forecast that Teleflex Incorporated will post 13.75 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Wednesday, May 15th will be issued a $0.34 dividend. The ex-dividend date is Tuesday, May 14th. This represents a $1.36 dividend on an annualized basis and a yield of 0.65%. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Teleflex Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Read More

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.